chrisvoncsefalvay/vaers-outcomes huggingface dataset:
liquid portion administered alone; liquid portion administered alone; This case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 10-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMXA636A, expiry date 31st May 2023) for prophylaxis.   On 15th October 2021, the patient received Menveo. On 15th October 2021, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The patient administered with Menveo liquid portion alone, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter consented to follow up.
First vaccine: pain at injection site Second vaccine, mild symptoms early on. Sever gastritis and nausea on 13th March. Resolved in 1 day
NUMB CHIN SYNDROME, STARTED ABOUT 30 MINUTES AFTER SHOT. LASTED ABOUT 24 HOURS. NO TREATMENT. FELT FATIGUED NEXT TWO DAYS BUT THAT WENT AWAY AFTER TWO DAYS;
pt felt dizzy and vomited after administration of all 3 vaccines. Felt better after a few minutes no signs or symptoms of trouble breathing or swelling
severe chest pressure and pain; severe chest pressure and pain; severe chest pressure and pain / it was so bad that I couldn't go back to sleep; physical pain; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, on 21Jan2021 (Batch/Lot Number: EK9231) (at the age of 70 years old) as dose 1, 0.3 mL single, COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On 26Jan2021 (at about 02:00 AM), the patient reported that while sleeping, she had a severe chest pressure and pain which went another way across the chest, right near the clavicle area. The patient reported that it was so bad that she couldn't go back to sleep and it stayed for a quite some time. The patient also has had some other physical pain on an unspecified date in Jan2021. The patient underwent lab tests and procedures on 27Jan2021, at about 10:00 AM, which included a negative COVID test result. The patient has not taken any treatment for the events. The patient was recovering from severe chest pressure and pain which were gradually disappearing on the time of the report. The outcome for the rest of the events was unknown.  No follow-up attempts are possible. No further information is expected.
2 weeks after I received the shot, I suddenly felt very ill and experienced severe pelvic pain and urinated blood on 09/10/21. The pain was so severe, I was rushed into the emergency room and treated. Upon investigation and various tests performed (such as a cat scan), the doctor assumed it was kidney stones, HOWEVER, there were no kidney stones present. The diagnosis was unknown and the doctor was uncertain what caused such pain and blood in my urine.
Pt felt dizzy s/p vaccination. Symptoms resolved with rest. Denies HA, chills, chest pain, SOB. Discharged home under stable condition.  BP 128/81 HR 73 SpO2 100% RA  RR 18, unlabored
p/vax pt exp arthritic pain throughout body, particularly in arm of inj; not relieved by ibuprofen or heat; few days later started felling better
had really bad headache on Tuesday; felt very bad the night; This is a spontaneous report from a non-contactable consumer (patient). An adult female patient received BNT162B2 (lot no. and expiry date were not reported), via an unspecified route of administration on 17Jan2021 at single dose for Covid-19 immunization. The patient's age at vaccination was reported as 50 (units unspecified). The patient is not pregnant. The patient's medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 17Jan2021 17:00, the patient reported that she felt very bad the night she took the vaccine; she could not even get out of bed. Had a horrible day the next day and had really bad headache on Tuesday (19Jan2021). She was going to take Tylenol. The events were assessed as non-serious. The outcome of the events was recovering.  No follow-up attempts are possible, information about batch number cannot be obtained.
PUI is at Ave. PUI was fully vaccinated however wife indicated why she was out of town he was exposed by someone and upon her return he was found non-responsive. He currently is in critical condition on a ventilator and currently experiencing kidney failure. Prognosis is not good. Patient died.
change in taste metal like taste; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 12Nov2021 14:00 (Lot number: FF2593) at the age of 57 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: INFLUENZA VACCINE taken for immunisation, administration date Sep2021; HYDROCODONE; TYLENOL. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EL9264, Location of injection: Arm Right, Vaccine Administration Time: 05:30 PM), administration date: 06Feb2021, when the patient was 56 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EL3247, Location of injection: Arm Right, Vaccine Administration Time: 12:00 PM), administration date: 16Jan2021, when the patient was 56 years old, for COVID-19 immunization. The following information was reported: DYSGEUSIA (non-serious) with onset Dec2021, outcome "not recovered", described as "change in taste metal like taste". The event "change in taste metal like taste" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of dysgeusia. Additional information- It was reported that facility where the most recent COVID-19 vaccine was administered was hospital.Prior to vaccination,the patient was not diagnosed with COVID-19 Since the vaccination,  the patient  had been tested for COVID-19. No follow-up attempts are possible. No further information is expected.
Chills; 4x3 inch red rash; hives, hivey; itchy rash; Tender rash; This non-serious case was reported by a consumer and described the occurrence of chills in a 55-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Additional patient notes included have no allergies, never had hives or rash before.   On 25-FEB-2023, the patient received Shingles vaccine. On 28-FEB-2023, 3 days after receiving Shingles vaccine, the patient experienced chills (Verbatim: Chills), red rash (Verbatim: 4x3 inch red rash), hives (Verbatim: hives, hivey), itchy rash (Verbatim: itchy rash) and tenderness (Verbatim: Tender rash).  On 03-MAR-2023, the outcome of the chills, red rash, hives, itchy rash and tenderness were recovered/resolved (duration 3 days).   It was unknown if the reporter considered the chills, red rash, hives, itchy rash and tenderness to be related to Shingles vaccine.     It was unknown if the company considered the chills, red rash, hives, itchy rash and tenderness to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 03-Mar-2023 This report was submitted via the online direct entry reporting system. The patient was very healthy. The patient experienced chills, 4x3 inch red, hive, itchy, very tender rash (not at injection site but lower in upper area).  The symptoms were not treated. The reporter consented to follow up.
fever; chills; headache; This case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Concurrent medical conditions included penicillin allergy.   On an unknown date, the patient received Shingles vaccine. On an unknown date, less than a week after receiving Shingles vaccine, the patient experienced fever, chills and headache. On an unknown date, the outcome of the fever, chills and headache were unknown.   It was unknown if the reporter considered the fever, chills and headache to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 25-MAY-2022 Reporter's Comments: The case was self reported by the patient via interactive digital media. The patient had the shot and got sick within about 18 hours of having it (fever, chills and headache).  The patient's physician warned saying that several people get this kind of a reaction. The follow-up would not possible as no contact details were available. On 25th May 2022, the case US2022AMR084987 was identified as duplicate case of US2022AMR084996.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR084996:Same reporter
felt fatigued; runny nose; Initial information regarding an unsolicited valid non-serious case received from a other health professional (Son of patient) on 18-Oct-2020.  This case involves an 81 years old male patient who experienced felt fatigued (fatigue) and runny nose (rhinorrhoea), while he received vaccine INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [FLUZONE].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 14-Oct-2020, the patient received a  dose of suspect INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED lot number not reported via unknown route.  On an unknown day, unknown latency after vaccination, the patient developed a non-serious felt fatigued (fatigue) and runny nose (rhinorrhoea).   It was not reported if the patient received a corrective treatment.  The outcome was Unknown for both events.  No further relevant information was reported.
Hardness under the skin has started to move towards the inside of her arm; Swollen hard lump under the skin the size of her palm; Spots of redness.; Rash on top of the hardness; Little lightheadedness; This spontaneous case was reported by a non-health professional (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Little lightheadedness), CONDITION AGGRAVATED (Hardness under the skin has started to move towards the inside of her arm), VACCINATION SITE INDURATION (Swollen hard lump under the skin the size of her palm), VACCINATION SITE ERYTHEMA (Spots of redness.) and VACCINATION SITE RASH (Rash on top of the hardness) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Heart failure. Concomitant products included RIVAROXABAN (XARELTO) and ATORVASTATIN CALCIUM, EZETIMIBE (STATIN EZ) for an unknown indication.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced DIZZINESS (Little lightheadedness). On 13-Jan-2021, the patient experienced VACCINATION SITE INDURATION (Swollen hard lump under the skin the size of her palm), VACCINATION SITE ERYTHEMA (Spots of redness.) and VACCINATION SITE RASH (Rash on top of the hardness). On 15-Jan-2021, the patient experienced CONDITION AGGRAVATED (Hardness under the skin has started to move towards the inside of her arm). The patient was treated with CEPHALEXIN [CEFALEXIN] for Vaccination site induration, at a dose of 500 mg. At the time of the report, DIZZINESS (Little lightheadedness), CONDITION AGGRAVATED (Hardness under the skin has started to move towards the inside of her arm), VACCINATION SITE ERYTHEMA (Spots of redness.) and VACCINATION SITE RASH (Rash on top of the hardness) outcome was unknown and VACCINATION SITE INDURATION (Swollen hard lump under the skin the size of her palm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Brief seizure lasting 17 days after first dose of Pfizer-BioNTech COVID vaccine
Myoclonic jerking, whole body, progressively getting worse over past 2 1/2 hours.
Please note: unknown series of vaccination.   An intern used the incorrect size needle to administer the Covid vaccine. The needle size used was a 5/8 inch needle, when the correct size that should have been used was a 1 inch needle. The correct dose was given to all patients. Based on CDC recommendations, there is no need to revaccinate any patient that was administered the dose in the wrong location; in this case the vaccine was given SubQ rather than intramuscular, based on the length of the needle. All patients were notified of this error and were given advise on what to expect. All patients were informed that no harm was done, the vaccine was still effective, and no additional dose is required based on CDC guidelines. As a result of these errors, reeducation was given to the pharmacy student, and the area within the pharmacy that contains all vaccination related supplied were relabeled to make it more clear for everyone administering vaccines.
Stroke like effects. Left side of my body from the top of my head to my knee went numb for three days. It was as if a line was drawn down the center of my body, left hemisphere was numb and insensitive. Severe pain in the left arm that left it unusable for two weeks. Then the injection site had scabbing after two weeks. Three weeks later I had a blood test to address pain that was in lower right intestinal area, the phlebotomist said my veins were hard and difficult to puncture. This has not been a problem for me in the past. The intestinal problem was diagnosed as gall stones. No treatment necessary, otherwise normal.
Narrative:  Patient is an 82-year-old male with a past medical history significant for B- cell chronic lymphocytic leukemia; OSA on BiPAP; chronic autoimmune hemolytic anemia; history of chronic diastolic heart failure (EF 50 to 55%); history of bilateral PE on apixaban; history of interstitial lung disease secondary to IPF; hypothyroidism - who was admitted on August 24 for sepsis 2/2 acute Covid pneumonia versus CAP. Patient received Pfizer vaccine on 1/11/21 and 2/1/2021. Started on remdesivir, dexamethasone, ceftriaxone, doxycycline. Admission complicated by atrial fibrillation with rapid ventricular response. Cardiology consulted. Patient's Lopressor increased from 25 mg twice daily to 50 mg twice daily. Rates controlled on increased dose. Apixaban dose also increased from 2.5 mg to 5 mg twice daily. CHA2DS2-VASc of 3. Mild initial hypoxia that improved quickly and patient on room air for majority of admission. Ultimately completed 4 days of remdesivir, dexamethasone. Discharged to complete 1 final day of Levaquin to complete 5-day course for community-acquired pneumonia. Patient to follow-up with cardiology in 3 to 4 weeks for consideration of DCCV. Of note, thyroid function tests within normal limits and TTE without significant changes from baseline. Discussed self-isolation recommendations, especially in regard to non- vaccinated grandchild.
I had a slight pain in my teeth for a few days, then I had pain on the right side of my face that lasted four days, very intense, a lot of pain from head to shoulder for several days, the pain did not go away. it still hurts, I get stabbing pains on the right side of my face
Pronounced Headache (3 days) Nausea (24 hours) Vomiting (30 minutes) Extreme fatigue (24 hours) Injection site pain (extreme 2 days) Injection site itching (2 days)
This is a 22 year old who received her primary smallpox on 02/17/2004.  No pregnancy test was taken the date of vaccination. She states that she had a negative pregnancy test 02/01/2004. The urine HCG test was done in the Emergency Department to rule out pregnancy. She began to experience nausea on or about 23 February 2004. She had another urine HCG done on 03/03/04 which was positive. She reported to Special Immunization on 03/02/2004 because of her concern about fetal vaccinia or other adverse side effects to her fetus as a result of smallpox vaccination.
Upon administering it was tough to get the needle in SQ. I don't know if it was a combination of the needle and her skin. I was able to administer at least half of the vaccine when she asked me to stop and I've never experienced this before. I've talked to her since she has been home and she said she is doing fine and not to worry about her. She isn't having any problems, but I'm concerned because I was unable to administer the whole vaccine.
Increased fatigue; Medium to large 3-inch knot to left deltoid with increase soreness and tender to touch; Medium to large 3-inch knot to left deltoid with increase soreness and tender to touch; This is a spontaneous report from a contactable healthcare professional (patient). A 48-year-old female (non-pregnant) patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL0142), via an unspecified route of administration in left arm, on 30Dec2020 08:15, at a single dose, for COVID-19 immunization. The patient's medical history included COVID-19. The patient's concomitant medications included topiramate and bupropion hydrochloride (WELLBUTRIN). The patient had no known allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Most recent COVID-19 vaccine was administered in the hospital. On 30Dec2020 at 4:30 PM, the patient had increased fatigue on the day of vaccination. Also, the patient had a medium to large 3-inch knot to left deltoid with increase soreness and tender to touch. No treatment was received for the adverse events. Since the vaccination, the patient had not been tested for COVID-19. The patient was recovering from the events.
LOSS OF TASTE 8/8, TONGUE NUMBNESS 8/9,PARALYZED RIGHT SIDE OF FACEON 8/10
This case was reported by a consumer via call center representative and described the occurrence of fever in a 74-year-old male patient who received SHINGRIX. On 21st May 2018, the patient received the 1st dose of SHINGRIX. On 21st May 2018, less than a day after receiving SHINGRIX, the patient experienced fever, muscle pain, upset stomach and headache. The patient was treated with TYLENOL. On an unknown date, the outcome of the fever, muscle pain, upset stomach and headache were not recovered/not resolved. The reporter considered the fever, muscle pain, upset stomach and headache to be related to SHINGRIX. Additional details were provided as follows: The patient declined to provided concomitant medications. The patient was administered SHINGRIX in the right arm in the evening. Around 9 pm, the patient developed fever and the body temperature was recorded as 100 degree F, headache, muscle aches and upset stomach. The patient was unable to provide full pharmacy demographics. The patient took TYLENOL to treat the fever. The patient had denied permission to contact their physician.
Fever of 101F, chills; dizziness, head rush, temporary loss of vision when standing; fatigue
Aches, Pain, tightening around chest, chills, skin painful to the touch, dizzy. Started at about 4:00pm 05/05/2021
Patient was sitting on the examination table and had a syncopal event within 10 minutes after receiving the vaccine.
Patient called and stated that she noticed a rash on her arm a couple of hours after her immunization.  It has started to spread and has become itchy.  We reccommended going to a Doctor to check out the reaction and to see if needs further treatment.  I did mention that she could take either Benadryl or Claritin to help on the way to the doctor
stiff neck; migraine; rash; vertigo spell; flu like symptoms; sweating; fever; chills; body ache; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (vertigo spell), MIGRAINE (migraine), RASH (rash) and MUSCULOSKELETAL STIFFNESS (stiff neck) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 30-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jul-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), HYPERHIDROSIS (sweating), PYREXIA (fever), CHILLS (chills) and MYALGIA (body ache). On 31-Jul-2021, the patient experienced VERTIGO (vertigo spell) (seriousness criterion hospitalization) and RASH (rash) (seriousness criterion hospitalization). On 02-Aug-2021, the patient experienced MIGRAINE (migraine) (seriousness criterion hospitalization) and MUSCULOSKELETAL STIFFNESS (stiff neck) (seriousness criterion hospitalization). The patient was hospitalized from 02-Aug-2021 to 04-Aug-2021 due to MIGRAINE, MUSCULOSKELETAL STIFFNESS, RASH and VERTIGO. The patient was treated with RIMEGEPANT SULFATE (NURTEC ODT) for Migraine, at an unspecified dose and frequency and IBUPROFEN for Migraine, at an unspecified dose and frequency. On 29-Jul-2021, INFLUENZA LIKE ILLNESS (flu like symptoms), HYPERHIDROSIS (sweating), PYREXIA (fever), CHILLS (chills) and MYALGIA (body ache) had resolved. At the time of the report, VERTIGO (vertigo spell), MIGRAINE (migraine), RASH (rash) and MUSCULOSKELETAL STIFFNESS (stiff neck) outcome was unknown.            Concomitant medication reported as unspecified birth control. On 02-Aug-21 patient saw her doctor for the rash that had spread to her entire body and stiff neck that she could not move from side to side. Treatment medications taken by patient did not help her migraine. Patient also reported taking an unspecified steroid for the rash.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, the patient's concomitant medication for birth control is a confounder.   This case was linked to MOD-2021-280143 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, the patient's concomitant medication for birth control is a confounder.
The next day after the shot I started getting a severe pain in my back and the pain started migrating up my back and over my shoulders and down to my fingers. the pain comes and goes and is very severe, it is a crippling pain. The pain keeps coming and going, I did go to the ER and my BP was very high, and the pain radiates across my chest. I was in the hospital for two days.